1-4 of 4
Dana Stafkey-Mailey
Close
Sort by
Journal Articles

Current Real-World Treatment Patterns and Outcomes in Patients with Relapsed/Refractory Multiple Myeloma

Jenny Willson, Amanda Bruno, Joanna Opalinska, Jeannene Nelson, Orsolya Lunacsek, Dana Stafkey-Mailey, Joanne Willey
Journal: Blood
Blood (2018) 132 (Supplement 1): 3290.
https://doi.org/10.1182/blood-2018-99-112954
Published: 2018
Journal Articles

Evaluation of Treatment Patterns Among Patients with Newly Diagnosed, Persistent, and Chronic Immune Thrombocytopenia (ITP) Treated with Eltrombopag in Real World Setting in the US

Dana Stafkey-Mailey, PharmD, PhD, Anuja Roy, PhD, Tasneem Lokhandwala, BPharm, MS, PhD, Jing Yuan, Pamela Landsman-Blumberg, MPH DrPH, Asif Siddiqui, PhD, Farhat Ghaznawi, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2078.
https://doi.org/10.1182/blood.V130.Suppl_1.2078.2078
Published: 2017
Journal Articles

Impact of a Patient-Centered Support Program on Treatment Compliance Among Patients with Multiple Myeloma

Nicole Cross, BS, Dale Hanna, Dana Stafkey-Mailey, PharmD, PhD, Michael Eaddy, PharmD, PhD, Manasi Suryavanshi, MPH
Journal: Blood
Blood (2016) 128 (22): 2389.
https://doi.org/10.1182/blood.V128.22.2389.2389
Published: 2016
Journal Articles

Racial/Ethnic Disparities of Erythropoiesis Stimulating Agent Use Among the Insured Poor: Pre- and Post-Safety Advisories

Dana Stafkey-Mailey, PharmD, PhD, Charles Bennett, MD, PhD, MPP, Michael Dickson, RPh, PhD
Journal: Blood
Blood (2010) 116 (21): 395.
https://doi.org/10.1182/blood.V116.21.395.395
Published: 2010